Skip to main content
. 2018 Jun 8;14(9):1081–1089. doi: 10.7150/ijbs.24692

Figure 4.

Figure 4

(A) Xenograft was performed using HepG2 stable cell lines with SMC1 knockdown and reexpression of wild type or S957DS966D mutant SMC1. Mice were sacrificed and photographed at day 32. (B) The tumor size was measured every 4 days and tumor volume was analyzed. (C) SMC1 S957DS966D mutant promotes xenograft tumor growth. At 32 days after injection, tumors were removed and photographed. (D) The tumor weight was calculated on day 32. Data are presented as mean ± SD (n=5). *P < 0.05 versus control.